ラジオサーノスティクスの世界市場レポート 2025年

ラジオサーノスティクス市場規模は、今後数年で急成長が見込まれます。2029年には複合年間成長率（CAGR）13.9％で169億4,000万米ドルに成長します。予測期間の成長は、標的がん治療の進歩、腫瘍学研究の拡大、慢性疾患の増加、theranosticアプリケーションの成長に起因すると考えられます。予測期間における主な動向としては、セラノスティック放射性医薬品の開発、がん領域以外への応用拡大、個別化放射性医薬品、ラジオサーノスティクスにおけるナノテクノロジー、規制シフト、標準化などが挙げられます。

がん罹患率の上昇は、今後のラジオサーノスティクス市場の成長を牽引すると予想されます。がんは、体内の特定の細胞が制御不能に開発され、他の部位に転移することを特徴とします。ラジオサーノスティクス薬は、診断用と治療用の放射性核種プローブをペアにすることで、個別化医療の概念を提供する腫瘍学で広く使用されています。これらのプローブは、治療効果を高め、臨床転帰を改善するために、患者の特定の状態に合わせて、特定の（典型的にはがん性の）細胞を選択的かつ標的的に検出し、治療することを可能にします。例えば、2024年1月、米国を拠点とするがん擁護に重点を置く非営利団体である米国がん協会（American Cancer Society）は、がん患者数が2023年の195万8310人から201万1140人に増加し、2.19％の伸びを示したと報告しています。このように、がんの有病率の増加がラジオサーノスティクス市場を推進しています。

個別化医療の採用拡大が、ラジオサーノスティクス市場の成長に寄与する見通しです。個別化医療は、個々の患者の特性に合わせた治療を行う革新的なヘルスケアアプローチであり、ラジオサーノスティクスによって促進されます。特定の放射性医薬品を利用するこのアプローチは、個別の分子標的の同定を可能にし、正確な診断と患者固有の特性に基づいたオーダーメイドの治療介入を可能にします。個別化医療連合によると、2022年に食品医薬品局医薬品評価研究センター（CDER）は37の新規分子生物学的製剤（NME）を承認し、その約34％は個別化医療に分類されました。個別化医療の採用が増加していることは、ラジオサーノスティクス市場の成長にとって重要な要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ラジオサーノスティクス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のラジオサーノスティクス市場：成長率分析
• 世界のラジオサーノスティクス市場の実績：規模と成長, 2019-2024
• 世界のラジオサーノスティクス市場の予測：規模と成長, 2024-2029, 2034F
• 世界ラジオサーノスティクス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のラジオサーノスティクス市場放射性同位元素による、実績と予測, 2019-2024, 2024-2029F, 2034F
• テクネチウム99
• ガリウム68
• ヨウ素131
• ヨウ素123
• フルデオキシグルコース-18F
• イットリウム90
• ルテチウム（Lu）177
• 銅（Cu）67
• 銅（Cu）64
• その他の放射性同位元素
• 世界のラジオサーノスティクス市場アプローチ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 標的治療
• ターゲット診断
• 世界のラジオサーノスティクス市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍学
• 非腫瘍学
• 世界のラジオサーノスティクス市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 製薬およびバイオテクノロジー企業
• その他のエンドユーザー
• 世界のラジオサーノスティクス市場、放射性同位元素によるテクネチウム99のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• テクネチウム99m
• テクネチウム-99過テクネチウム酸塩
• 世界のラジオサーノスティクス市場、ガリウム68のサブセグメンテーション、放射性同位元素による、実績と予測, 2019-2024, 2024-2029F, 2034F
• ガリウム68ドタテート
• ガリウム68 PSMA
• 世界のラジオサーノスティクス市場、放射性同位元素によるヨウ素131のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 甲状腺がん治療のためのヨウ素131
• 甲状腺機能亢進症の治療のためのヨウ素131
• 世界のラジオサーノスティクス市場、放射性同位元素によるヨウ素123のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 甲状腺スキャンのためのヨウ素123
• 心臓画像診断のためのヨウ素123
• 世界のラジオサーノスティクス市場、放射性同位元素によるフルデオキシグルコース-18F（FDG）のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍学画像診断のためのFDG
• 脳画像診断のためのFDG
• 世界のラジオサーノスティクス市場、放射性同位元素によるイットリウム90のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 肝臓がんに対するイットリウム90マイクロスフェア
• 放射免疫療法のためのイットリウム90
• 世界のラジオサーノスティクス市場、放射性同位元素によるルテチウム（Lu）177のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 前立腺がんに対するルテチウム177 PSMA
• 神経内分泌腫瘍に対するルテチウム-177 DOTATATE
• 世界のラジオサーノスティクス市場、放射性同位元素による銅（Cu）67のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 標的放射線療法のための銅67
• 臨床試験における銅67
• 世界のラジオサーノスティクス市場、放射性同位元素による銅（Cu）64のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• PETイメージング用銅64
• 放射線治療用銅64
• 世界のラジオサーノスティクス市場、その他の放射性同位元素のサブセグメンテーション、放射性同位元素別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ラジウム-223、サマリウム-153
• セラノスティクスにおけるその他の新興放射性同位元素

第7章 地域別・国別分析

• 世界のラジオサーノスティクス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のラジオサーノスティクス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ラジオサーノスティクス市場：競合情勢
• ラジオサーノスティクス市場：企業プロファイル
  • Lantheus Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • GE Healthcare Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Siemens Healthineers
• Orano Med
• Curium SAS
• IBA Molecular
• The Eckert & Ziegler Group
• Advanced Accelerator Applications（AAA）
• Telix Pharmaceuticals Limited.
• Abdera Therapeutics
• Blue Earth Diagnostics
• Sirtex Medical Limited
• Y-mAbs Therapeutics Inc.
• ITM Radiopharma
• NorthStar Medical Radioisotopes LLC
• Trasis S.A.
• Molecular Targeting Technologies Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ラジオサーノスティクス市場2029：新たな機会を提供する国
• ラジオサーノスティクス市場2029：新たな機会を提供するセグメント
• ラジオサーノスティクス市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Radiotheranostics refers to a medical approach that combines diagnoses and treatments using imaging methods with radioactive substances to precisely identify specific targets within the body. This method is employed for delivering targeted radiation therapy to defined locations, enabling precise and tailored cancer treatment while minimizing damage to healthy tissues. This approach enhances treatment outcomes and improves patient care.

The primary radiotheranostics radioisotopes include technetium-99, gallium-68, iodine-131, iodine-123, fludeoxyglucose-18F, yttrium-90, lutetium (Lu) 177, copper (Cu) 67, copper (Cu) 64, and others. Technetium (Tc) is a silver-gray radioactive metal that occurs naturally at extremely low levels in the earth's crust but is predominantly man-made. It is used for skeletal and heart muscle scans and imaging of various organs such as the brain, thyroid, lungs, liver, spleen, kidneys, gall bladder, bone marrow, salivary and lacrimal glands, as well as in some specialized medical research. The different approaches include targeted therapeutic and targeted diagnostic applications in both oncology and non-oncology. The end users of this technology include hospitals and clinics, pharmaceutical and biotechnology companies, and others.

The radio theranostics market research report is one of a series of new reports from The Business Research Company that provides radio theranostics market statistics, including radio theranostics industry global market size, regional shares, competitors with a radio theranostics market share, detailed radio theranostics market segments, market trends, and opportunities, and any further data you may need to thrive in the radio theranostics industry. This radio theranostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The radiotheranostics market size has grown rapidly in recent years. It will grow from $8.79 billion in 2024 to $10.07 billion in 2025 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to advancements in nuclear medicine, a rise in cancer cases, personalized medicine development, advances in radiopharmaceuticals, regulatory approvals and standards

The radiotheranostics market size is expected to see rapid growth in the next few years. It will grow to $16.94 billion in 2029 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to advancements in targeted cancer therapies, expansion in oncology research, rise in chronic diseases, and growth in theranostic applications. Major trends in the forecast period include theranostic radiopharmaceutical development, expanding applications beyond oncology, personalized radiopharmaceuticals, nanotechnology in radiotheranostics, regulatory shifts and standardization.

The rising incidence of cancer is anticipated to drive the growth of the radiotheranostics market in the future. Cancer is characterized by the uncontrolled development of certain cells in the body that spread to other areas. Radiotheranostics medications are widely used in oncology to provide the concept of personalized medicine through paired diagnostic and therapeutic radionuclide probes. These probes enable selective and targeted detection and treatment of specific (typically cancerous) cells, tailored to the patient's specific condition to enhance treatment efficacy and improve clinical outcomes. For example, in January 2024, the American Cancer Society, a US-based nonprofit organization focused on cancer advocacy, reported an increase in cancer cases to 2,001,140, up from 1,958,310 in 2023, marking a growth of 2.19%. Thus, the increasing prevalence of cancer is propelling the radiotheranostics market.

The increasing adoption of personalized medicine is poised to contribute to the growth of the radiotheranostics market. Personalized medicine, an innovative healthcare approach tailoring medical treatments to individual patient characteristics, is facilitated by radiotheranostics. This approach, utilizing specific radiopharmaceuticals, enables the identification of individualized molecular targets, allowing for precise diagnosis and tailored therapeutic interventions based on the patient's unique characteristics. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% classified as personalized medicines, according to the Personalized Medicine Coalition. The increasing adoption of personalized medicine is a key driver for the growth of the radiotheranostics market.

An emerging trend in the radiotheranostics market is the focus on product innovations. Major companies are directing their efforts towards creating innovative products to solidify their market positions. For instance, Advanced Cyclotron Systems Inc., a Canada-based company specializing in cyclotrons for medical isotope production, introduced TR-ALPHA in May 2023. This innovation is designed for the production of alpha-emitting radioisotopes used in cancer treatment. TR-ALPHA addresses market demands for a low-cost cyclotron capable of producing substantial amounts of Astatine-211, a promising alpha-emitting radioisotope. This product is smaller, more cost-effective, and easier to operate compared to previous cyclotron models, making it an ideal solution for efficiently producing therapeutic alpha-emitting radioisotopes.

Major companies in the radiotheranostics market are forming strategic partnerships to develop new products and strengthen their market positions. Collaborations and partnerships in this market facilitate the pooling of resources, expertise, and research efforts, accelerating the development, commercialization, and widespread adoption of advanced diagnostic and therapeutic solutions. In April 2022, Ion Beam Applications partnered with SCK CEN to advance the production of the radioisotope Actinium-225, a crucial element in cancer treatment. This collaboration aims to establish a state-of-the-art production facility in Mol, Belgium, combining expertise in particle accelerators and the provision of rare raw materials. Such collaborations are crucial for making radiotheranostic solutions commercially viable for treating various cancers with enhanced precision.

In June 2023, Ariceum Therapeutics GmbH, a Germany-based radiopharmaceutical company, acquired Theragnostics Ltd. for $41.5 million. This strategic acquisition is intended to broaden Ariceum's portfolio of therapeutic and diagnostic assets in late preclinical and early clinical development and expand its operations in the US. Theragnostics Ltd., a US-based radiopharmaceutical company, specializes in offering radio-theranostic solutions.

Major companies operating in the radiotheranostics market include Lantheus Holdings Inc., Cardinal Health Inc., GE Healthcare Inc., Bayer AG, Novartis AG, Siemens Healthineers, Orano Med, Curium SAS, IBA Molecular, The Eckert & Ziegler Group, Advanced Accelerator Applications (AAA), Telix Pharmaceuticals Limited., Abdera Therapeutics, Blue Earth Diagnostics, Sirtex Medical Limited, Y-mAbs Therapeutics Inc., ITM Radiopharma, NorthStar Medical Radioisotopes LLC, Trasis S.A., Molecular Targeting Technologies Inc., RadioMedix Inc, Clarity Pharmaceuticals, Actinium Pharmaceuticals Inc., Navidea Biopharmaceuticals Inc.

North America was the largest region in the radiotheranostics market in 2024. The regions covered in the radiotheranostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the radiotheranostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The radiotheranostics market consists of sales of iodine-125, radium-223 (223Ra), astatin-211 (211At), actinium-225 (225Ac), lead-212 (212Pb), bismuth-212 (212Bi), thorium-227, strontium-89 (89Sr), rhenium-188 (188Re), and samarium-153 (153Sm). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Radiotheranostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on radiotheranostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for radiotheranostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The radiotheranostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Radioisotope: Technetium-99; Gallium-68; Iodine-131; Iodine-123; Fludeoxyglucose-18F; Yttrium-90; Lutetium (Lu) 177; Copper (Cu) 67; Copper (Cu) 64; Other Radioisotopes
• 2) By Approach: Targeted Therapeutic; Targeted Diagnostic
• 3) By Application: Oncology; Non-Oncology
• 4) By End-Users: Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End-Users
• Subsegments:
• 1) By Technetium-99: Technetium-99m; Technetium-99 Pertechnetate
• 2) By Gallium-68: Gallium-68 DOTATATE; Gallium-68 PSMA
• 3) By Iodine-131: Iodine-131 For Thyroid Cancer Treatment; Iodine-131 For Hyperthyroidism Treatment
• 4) By Iodine-123: Iodine-123 For Thyroid Scans; Iodine-123 For Cardiac Imaging
• 5) By Fludeoxyglucose-18F (FDG): FDG For Oncology Imaging; FDG For Brain Imaging
• 6) By Yttrium-90: Yttrium-90 Microspheres For Liver Cancer; Yttrium-90 For Radioimmunotherapy
• 7) By Lutetium (Lu) 177: Lutetium-177 PSMA For Prostate Cancer; Lutetium-177 DOTATATE For Neuroendocrine Tumors
• 8) By Copper (Cu) 67: Copper-67 For Targeted Radiotherapy; Copper-67 In Clinical Trials
• 9) By Copper (Cu) 64: Copper-64 For PET Imaging; Copper-64 For Radiotherapy
• 10) By Other Radioisotopes: Radium-223; Samarium-153; Other Emerging Radioisotopes In Theranostics
• Companies Mentioned: Lantheus Holdings Inc.; Cardinal Health Inc.; GE Healthcare Inc.; Bayer AG; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Radiotheranostics Market Characteristics

3. Radiotheranostics Market Trends And Strategies

4. Radiotheranostics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Radiotheranostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Radiotheranostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Radiotheranostics Market Growth Rate Analysis
• 5.4. Global Radiotheranostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Radiotheranostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Radiotheranostics Total Addressable Market (TAM)

6. Radiotheranostics Market Segmentation

• 6.1. Global Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Technetium-99
• Gallium-68
• Iodine-131
• Iodine-123
• Fludeoxyglucose-18F
• Yttrium-90
• Lutetium (Lu) 177
• Copper (Cu) 67
• Copper (Cu) 64
• Other Radioisotopes
• 6.2. Global Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Targeted Therapeutic
• Targeted Diagnostic
• 6.3. Global Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Non-Oncology
• 6.4. Global Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Pharmaceutical And Biotechnology Companies
• Other End-Users
• 6.5. Global Radiotheranostics Market, Sub-Segmentation Of Technetium-99, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Technetium-99m
• Technetium-99 Pertechnetate
• 6.6. Global Radiotheranostics Market, Sub-Segmentation Of Gallium-68, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gallium-68 DOTATATE
• Gallium-68 PSMA
• 6.7. Global Radiotheranostics Market, Sub-Segmentation Of Iodine-131, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Iodine-131 For Thyroid Cancer Treatment
• Iodine-131 For Hyperthyroidism Treatment
• 6.8. Global Radiotheranostics Market, Sub-Segmentation Of Iodine-123, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Iodine-123 For Thyroid Scans
• Iodine-123 For Cardiac Imaging
• 6.9. Global Radiotheranostics Market, Sub-Segmentation Of Fludeoxyglucose-18F (FDG), By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• FDG For Oncology Imaging
• FDG For Brain Imaging
• 6.10. Global Radiotheranostics Market, Sub-Segmentation Of Yttrium-90, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Yttrium-90 Microspheres For Liver Cancer
• Yttrium-90 For Radioimmunotherapy
• 6.11. Global Radiotheranostics Market, Sub-Segmentation Of Lutetium (Lu) 177, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lutetium-177 PSMA For Prostate Cancer
• Lutetium-177 DOTATATE For Neuroendocrine Tumors
• 6.12. Global Radiotheranostics Market, Sub-Segmentation Of Copper (Cu) 67, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Copper-67 For Targeted Radiotherapy
• Copper-67 In Clinical Trials
• 6.13. Global Radiotheranostics Market, Sub-Segmentation Of Copper (Cu) 64, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Copper-64 For PET Imaging
• Copper-64 For Radiotherapy
• 6.14. Global Radiotheranostics Market, Sub-Segmentation Of Other Radioisotopes, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Radium-223; Samarium-153
• Other Emerging Radioisotopes In Theranostics

7. Radiotheranostics Market Regional And Country Analysis

• 7.1. Global Radiotheranostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Radiotheranostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Radiotheranostics Market

• 8.1. Asia-Pacific Radiotheranostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Radiotheranostics Market

• 9.1. China Radiotheranostics Market Overview
• 9.2. China Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Radiotheranostics Market

• 10.1. India Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Radiotheranostics Market

• 11.1. Japan Radiotheranostics Market Overview
• 11.2. Japan Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Radiotheranostics Market

• 12.1. Australia Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Radiotheranostics Market

• 13.1. Indonesia Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Radiotheranostics Market

• 14.1. South Korea Radiotheranostics Market Overview
• 14.2. South Korea Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Radiotheranostics Market

• 15.1. Western Europe Radiotheranostics Market Overview
• 15.2. Western Europe Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Radiotheranostics Market

• 16.1. UK Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Radiotheranostics Market

• 17.1. Germany Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Radiotheranostics Market

• 18.1. France Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Radiotheranostics Market

• 19.1. Italy Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Radiotheranostics Market

• 20.1. Spain Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Radiotheranostics Market

• 21.1. Eastern Europe Radiotheranostics Market Overview
• 21.2. Eastern Europe Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Radiotheranostics Market

• 22.1. Russia Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Radiotheranostics Market

• 23.1. North America Radiotheranostics Market Overview
• 23.2. North America Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Radiotheranostics Market

• 24.1. USA Radiotheranostics Market Overview
• 24.2. USA Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Radiotheranostics Market

• 25.1. Canada Radiotheranostics Market Overview
• 25.2. Canada Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Radiotheranostics Market

• 26.1. South America Radiotheranostics Market Overview
• 26.2. South America Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Radiotheranostics Market

• 27.1. Brazil Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Radiotheranostics Market

• 28.1. Middle East Radiotheranostics Market Overview
• 28.2. Middle East Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Radiotheranostics Market

• 29.1. Africa Radiotheranostics Market Overview
• 29.2. Africa Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Radiotheranostics Market Competitive Landscape And Company Profiles

• 30.1. Radiotheranostics Market Competitive Landscape
• 30.2. Radiotheranostics Market Company Profiles
  • 30.2.1. Lantheus Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GE Healthcare Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Radiotheranostics Market Other Major And Innovative Companies

• 31.1. Siemens Healthineers
• 31.2. Orano Med
• 31.3. Curium SAS
• 31.4. IBA Molecular
• 31.5. The Eckert & Ziegler Group
• 31.6. Advanced Accelerator Applications (AAA)
• 31.7. Telix Pharmaceuticals Limited.
• 31.8. Abdera Therapeutics
• 31.9. Blue Earth Diagnostics
• 31.10. Sirtex Medical Limited
• 31.11. Y-mAbs Therapeutics Inc.
• 31.12. ITM Radiopharma
• 31.13. NorthStar Medical Radioisotopes LLC
• 31.14. Trasis S.A.
• 31.15. Molecular Targeting Technologies Inc.

32. Global Radiotheranostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Radiotheranostics Market

34. Recent Developments In The Radiotheranostics Market

35. Radiotheranostics Market High Potential Countries, Segments and Strategies

• 35.1 Radiotheranostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Radiotheranostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Radiotheranostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer